RKDA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
RKDA is not a good buy right now. With no Intellectia buy signals, a bearish moving-average stack (SMA_200 > SMA_20 > SMA_5), weakening fundamentals in 2025/Q3, and no near-term news catalysts, the risk/reward is unfavorable for an impatient buyer looking to enter immediately.
Trend/structure: Bearish trend signal from moving averages (SMA_200 > SMA_20 > SMA_5), implying price is still in a downtrend/weak structure. Momentum: MACD histogram is slightly positive (0.02) but positively contracting, which often indicates bullish momentum is fading rather than accelerating. RSI_6 at ~24 suggests short-term oversold conditions (potential for a bounce), but oversold can persist in downtrends. Levels: Pivot 2.245 is the key reclaim level for bulls. Immediate support is S1 2.131 and S2 2.06; a break below ~2.06 increases downside risk. Resistance sits at R1 2.36 and R2 2.431; price needs to regain and hold above 2.245–2.36 to shift the short-term tone. Near-term odds (pattern-based): Model suggests ~60% chance of a small dip next day (-0.41%), but modest upside over the next week (+2.45%) and month (+5.36%). Given the dominant bearish MA structure and fading MACD, that upside is not strong enough to justify an impatient buy.
Intellectia Proprietary Trading Signals
RSI_6 near oversold levels could enable a technical bounce if support at ~2.13–2.06 holds.
Pattern-based projection points to modest upside potential over 1 week to 1 month.
No notable hedge fund/insider trend flags recently (neutral).
Primary trend remains bearish (SMA_200 > SMA_20 > SMA_5), which typically caps rallies.
MACD is positive but contracting, suggesting weakening upside momentum.
Pre-market is down (-2.38%), indicating soft immediate sentiment.
No news catalysts in the past week to spark a re-rating.
No notable insider accumulation or hedge fund buying trend (neutral).
Latest quarter: 2025/Q3. Revenue: 1.302M, down 15.29% YoY (contraction). Net income: 856K, down 153.10% YoY (sharp deterioration vs prior year). EPS: 0.62, down 152.54% YoY. Gross margin: 32.1, down 25.14% YoY. Overall: The quarter shows weakening growth and profitability trends, which undermines confidence in a sustained upside move without a clear catalyst.
No analyst rating/price target change data was provided, so there is no identifiable positive Wall Street momentum or recent upgrade-driven catalyst. Pros (inferred): potential oversold bounce. Cons: lack of visible analyst support/updates combined with deteriorating 2025/Q3 fundamentals and a bearish technical backdrop.
